MedPath

Multi-Component Breath Alcohol Intervention

Not Applicable
Active, not recruiting
Conditions
Alcohol Use
Alcohol Drinking
Drinking Behavior
Registration Number
NCT06124898
Lead Sponsor
Northeastern University
Brief Summary

This is the first stage of a three-stage, NIH-funded study to develop and test initially a multi-modal intervention concerning blood/breath alcohol concentration for young adults. The multimodal intervention will be made up of brief telehealth counseling and psychoeducation and use of three mobile technologies to facilitate moderate drinking. In the first stage of the study, we will conduct formative research to obtain input from the study population, test initially the telehealth version of the brief counseling and psychoeducation and to develop a simple, "low tech" approach to coaching participants to use the three mobile technologies in typical drinking situations. Participation will last approximately one month.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
115
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
Technology utilizationAcross the field testing period, 2-4 weeks

Percentage of reported drinking days on which one reports that moderate drinking technology use has occurred

UsabilityAt the end of the field testing period, 2-4 weeks

Score on acceptability subscale of Modified System Usability Scale

AcceptabilityAt the end of the field testing period, 2-4 weeks

Score on acceptability subscale of Modified System Usability Scale

Secondary Outcome Measures
NameTimeMethod
Negative consquencesAt the end of the field testing period, 2-4 weeks

Score on the Young Adult Alcohol Consequences Questionnaire

Drinks per drinking dayAcross the field testing period, 2-4 weeks

Number of drinks per day during field testing period

Estimated blood alcohol contentAcross the field testing period, 2-4 weeks

Average estimated blood alcohol content reached on drinking days

Trial Locations

Locations (1)

EDGE Lab

🇺🇸

Boston, Massachusetts, United States

EDGE Lab
🇺🇸Boston, Massachusetts, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.